Alloimmune blood transfusion reaction
Alloimmunisation may result from transfusion with red cells that are of different phenotype to the patient. Also, with repeated transfusions, the recipient may develop antibodies to leucocytes and platelets in the transfused blood.
Alloimmunisation usually occurs from days to weeks after infusion:
- 75% of Rh negative patients given Rh positive blood develop antibodies to Rh D
- more than 10% of repeatedly transfused patients develop antibodies to white cells and/or platelets
Prevention:
- avoid transfusion of Rh D positive blood to Rh D negative patients
- use filtered blood from which the majority of leucocytes and platelets have been removed
Reference:
- Panch SR, Montemayor-Garcia C, Klein HG. Hemolytic transfusion reactions. N Engl J Med. 2019 Jul 11;381(2):150-62.
Related pages
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.